Strikingly, mice with combined M1R and M3R deficiency develop as many colon tumors as control mice (Cheng et al., 2014); that is, M1R deficiency negates the anti-neoplastic effects of M3R deficiency. The gene discussed is CHRM1; the disease is colonic neoplasm.